Immuneering Corp (IMRX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $142.2K | +67.6% |
| 2024 | $84.9K | -75.2% |
| 2023 | $342.7K | -53.8% |
| 2022 | $742.5K | +1121.5% |
| 2021 | $60.8K | +13.8% |
| 2020 | $53.4K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $142.2K | +67.6% |
| 2024 | $84.9K | -75.2% |
| 2023 | $342.7K | -53.8% |
| 2022 | $742.5K | +1121.5% |
| 2021 | $60.8K | +13.8% |
| 2020 | $53.4K | — |